PT
PTC Therapeutics Inc
🇩🇪XFRA.BH3GermanyHealthcare
€56.24EURdown -0.76 (-1.33%)OpenEnd of day5:04 PM
Price€56.24-0.76 (-1.33%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US69366J2006
- CUSIP
- Not reported
Company
- Employees
- 991
- Headquarters
- Warren, United States
- Website
- https://www.ptcbio.com
- CEO
- Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Market
- Shares outstanding
- 80.3M
- Market cap
- €4.52B
Highlights
- Market cap
- €4.52B
- EPS LTM
- -$0.48calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.01B-42.84%down year on year
- Net income
- -$38.38M-106.1%down year on year
- Gross margin
- 82.14%-15.4%down year on year
- Free cash flow
- -$332.56M-148.83%down year on year
Other listings
- XDUS.BH3Düsseldorf Stock Exchange
- XMUN.BH3Munich Stock Exchange
- XSTU.BH3Stuttgart Stock Exchange
- XBER.BH3Berlin Stock Exchange
- XNAS.PTCTNasdaq
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.